GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Cash Flow
USA - New York Stock Exchange - NYSE:DNA - US37611X2099 - Common Stock
8.7 USD
+0.39 (+4.69%)
8.77 USD
+0.07 (+0.8%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -339.55M | -547.03M | -892.87M | -2.11B | -1.84B | |||
| Depreciation Amortization | 60.98M | 63.02M | 70.51M | 42.55M | 29.08M | |||
| Income Taxes - Deferred | N/A | -936.00K | -801.00K | -14.61M | N/A | |||
| Change In Working Capital | -18.32M | -89.67M | 29.84M | -37.01M | -61.54M | |||
| Interest Paid | N/A | 32.00K | 83.00K | 90.00K | 2.37M | |||
| Taxes Paid | N/A | 894.00K | 670.00K | 0.00 | 60.00K | |||
| Other non cash items | 132.01M | 255.03M | 497.83M | 1.86B | 1.62B | |||
| OPERATING CASH FLOW | -165.82M | -319.58M | -295.50M | -252.20M | -253.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -21.37M | -62.54M | -40.80M | -52.27M | -56.52M | |||
| Other Investing Activity | -327.10M | 305.00K | -39.89M | -15.12M | -16.74M | |||
| INVESTING CASH FLOW | -348.47M | -62.24M | -80.69M | -67.39M | -73.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -532.00K | -897.00K | -1.29M | -1.24M | -1.12M | |||
| Stock Issued/Repurchased | 10.32M | 84.00K | 93.00K | 99.54M | 1.48B | |||
| Other Financing Activity | -355.00K | -926.00K | -2.01M | -2.97M | 50.47M | |||
| FINANCING CASH FLOW | 9.43M | -1.74M | -3.22M | 95.34M | 1.53B | |||
| Exchange Rate Effect | 280.00K | -281.00K | -588.00K | 910.00K | -20.00K | |||
| CHANGE IN CASH | -504.58M | -383.84M | -380.00M | -223.34M | 1.21B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -165.82M | -319.58M | -295.50M | -252.20M | -253.82M | |||
| Capital Expenditure | -21.37M | -62.54M | -40.80M | -52.27M | -56.52M | |||
| FREE CASH FLOW | -187.19M | -382.13M | -336.30M | -304.47M | -310.34M | |||
All data in USD